- Home
- NBIX vs BG Comparison
NBIX vs BG Comparison
Compare NBIX & BG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NBIX | BG |
|---|---|---|
| Founded | 1992 | 1818 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.2B | 18.1B |
| IPO Year | 1996 | N/A |
Fundamental Metrics
Financial Performance| Metric | NBIX | BG |
|---|---|---|
| Price | $142.31 | $92.10 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 21 | 6 |
| Target Price | ★ $176.19 | $114.00 |
| AVG Volume (30 Days) | 977.3K | ★ 1.3M |
| Earning Date | 02-05-2026 | 02-04-2026 |
| Dividend Yield | N/A | ★ 3.01% |
| EPS Growth | ★ 12.44 | 9.16 |
| EPS | 4.19 | ★ 8.69 |
| Revenue | $2,682,700,000.00 | ★ $60,109,000,000.00 |
| Revenue This Year | $23.76 | $28.45 |
| Revenue Next Year | $18.01 | $26.02 |
| P/E Ratio | $33.80 | ★ $10.69 |
| Revenue Growth | ★ 19.61 | 10.29 |
| 52 Week Low | $84.23 | $67.40 |
| 52 Week High | $160.18 | $99.55 |
Technical Indicators
Market Signals| Indicator | NBIX | BG |
|---|---|---|
| Relative Strength Index (RSI) | 39.26 | 44.93 |
| Support Level | $151.09 | $90.11 |
| Resistance Level | $155.55 | $94.94 |
| Average True Range (ATR) | 4.52 | 2.20 |
| MACD | -1.41 | -0.29 |
| Stochastic Oscillator | 5.75 | 30.18 |
Price Performance
Historical ComparisonAbout NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
About BG Bunge Limited
Bunge Global SA formerly Bunge Ltd is an agribusiness and food company with operations along the farm-to-consumer food chain. The company segments include Agribusiness; Refined and Specialty Oils; Milling; Sugar and Bioenergy and Corporate and Other. It generates maximum revenue from the Agribusiness segment. The company is an oilseed processor and producer of vegetable oils and protein meals, based on processing capacity, a grain processor, the seller of packaged plant-based oils, producer and seller of wheat flour, bakery mixes and corn-based products in North and South America.